X-151604667-C-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_173493.3(PASD1):c.50C>A(p.Ser17Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000915 in 1,092,927 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_173493.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PASD1 | NM_173493.3 | c.50C>A | p.Ser17Tyr | missense_variant | 3/16 | ENST00000370357.5 | NP_775764.2 | |
PASD1 | XM_011531102.3 | c.50C>A | p.Ser17Tyr | missense_variant | 3/16 | XP_011529404.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PASD1 | ENST00000370357.5 | c.50C>A | p.Ser17Tyr | missense_variant | 3/16 | 1 | NM_173493.3 | ENSP00000359382.4 | ||
PASD1 | ENST00000464219.1 | n.188C>A | non_coding_transcript_exon_variant | 3/15 | 2 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 exomes AF: 0.0000283 AC: 5AN: 176400Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 61754
GnomAD4 exome AF: 0.00000915 AC: 10AN: 1092927Hom.: 0 Cov.: 27 AF XY: 0.0000111 AC XY: 4AN XY: 359025
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 20, 2024 | The c.50C>A (p.S17Y) alteration is located in exon 3 (coding exon 2) of the PASD1 gene. This alteration results from a C to A substitution at nucleotide position 50, causing the serine (S) at amino acid position 17 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at